References
- Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. doi: 10.3322/caac.21492
- Pang T, Wang S, Gao M, Kang H, Zhao Y, Yao Y, et al. HPV18 E7 induces the over-transcription of eIF4E gene in cervical cancer. Iran J Basic Med Sci 2015; 18: 684-90. PMID: 26351560
- Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-60. doi: 10.1038/nrc2886
- Santin A D, Zhan F, Bignotti E, Siegel E R, Cane S, Bellone S, et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005; 331: 269-91. doi: 10.1016/j.virol.2004.09.045
- Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget 2014; 5: 10976-96. doi: 10.18632/ oncotarget.2770
- Sun L, Luo H, Liao Q, Bu D, Zhao G, Liu C, et al. Systematic study of human long intergenic non-coding RNAs and their impact on cancer. Sci China Life Sci 2013; 56: 324-34. doi: 10.1007/s11427-013-4460-x
- Ching T, Peplowska K, Huang S, Zhu X, Shen Y, Molnar J, et al. Pan-cancer analyses reveal long intergenic non-coding RNAs relevant to tumor diagnosis, subtyping and prognosis. EBioMedicine 2016; 7: 62-72. doi: 10.1016/j. ebiom.2016.03.023
- Yang M, Zhai X, Xia B, Wang Y, Lou G. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. Tumour Biol 2015; 36: 7615-22. doi: 10.1007/s13277-015-3465-4
- Han D, Wang J, Cheng G. LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis. Oncotarget 2018; 9: 2395-409. doi: 10.18632/oncotarget.23416
- Tian Z, Cao S, Li C, Xu M, Wei H, Yang H, et al. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1. J Cell Physiol 2019; 234: 4799-4811. doi: 10.1002/jcp.27279
- Chen Y, Du H, Bao L, Liu W. LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214. Cancer Biol Med 2018; 15: 238-250. doi: 10.20892/j.issn.2095-3941.2017.0174
- Ding Y, Fang Q, Li Y, Wang Y. Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140. Mamm Genome 2019. doi: 10.1007/s00335-019-09808-1
- Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader J S. The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis. PLoS One 2016; 11: e0156274. doi: 10.1371/journal. pone.0156274
- Dong G, Liang X, Wang D, Gao H, Wang L, Wang L, et al. High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation. Med Oncol 2014; 31: 57. doi: 10.1007/s12032-014-0057-x
- Muhammad S, Tang Q, Wei L, Zhang Q, Wang G, Muhammad B U, et al. miRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 gene. Exp Ther Med 2019; 17: 260-272. doi: 10.3892/etm.2018.6902
- Ma H P, Kong W X, Li X Y, Li W, Zhang Y, Wu Y. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR. Oncol Rep 2019. doi: 10.3892/or.2019.6983
- Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586-91. doi: 10.1016/j.cell.2009.02.005
- Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y, et al. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Mol Cancer 2017; 16: 139. doi: 10.1186/s12943-017-0708-6
- Lan H, Chen W, He G, Yang S. miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. Biomed Pharmacother 2015; 75: 117-22. doi: 10.1016/j.biopha.2015.07.035
- Zhang Y, Xu J. MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression. Biochem Biophys Res Commun 2016; 473: 342-8. doi: 10.1016/j.bbrc.2016.03.116
- Li J, Zou K, Yu L, Zhao W, Lu Y, Mao J, et al. MicroRNA-140 inhibits the epithelial-mesenchymal transition and metastasis in colorectal cancer. Mol Ther Nucleic Acids 2018; 10: 426-37. doi: 10.1016/j.omtn.2017.12.022
- Dong P, Xiong Y, Hanley S J B, Yue J, Watari H. Musashi-2, a novel onco-protein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation. J Exp Clin Cancer Res 2017; 36: 150. doi: 10.1186/s13046-017-0617-y
- Dong J, Su M, Chang W, Zhang K, Wu S, Xu T. Long non-coding RNAs on the stage of cervical cancer. Oncol Rep 2017; 38: 1923-31. doi: 10.3892/ or.2017.5905
- Zhang Y, Yang G, Luo Y. Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a. Exp Ther Med 2019; 17: 1337-45. doi: 10.3892/etm.2018.7083
- Zou M F, Ling J, Wu Q Y, Zhang C X. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2. Eur Rev Med Pharmacol Sci 2018; 22: 7183-8. doi: 10.26355/eurrev_201811_16251
- Wan L, Sun M, Liu G J, Wei C C, Zhang EB, Kong R, et al. Long noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression. Mol Cancer Ther 2016; 15: 1082-94. doi: 10.1158/1535-7163.MCT-15-0707
- Ping G, Xiong W, Zhang L, Li Y, Zhang Y, Zhao Y. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer. Am J Transl Res 2018; 10: 138-49. PMID: 29423000
- Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159-66. doi: 10.1016/j. canlet.2013.06.013
- Kim J, Piao H L, Kim B J, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 2018; 50: 1705-15. doi: 10.1038/s41588-018-0252-3
- Zhang R, Li J, Yan X, Jin K, Li W, Liu X, et al. Long noncoding RNA plasmacytoma variant translocation 1 (PVT1) promotes colon cancer progression via endogenous sponging miR-26b. Med Sci Monit 2018; 24: 8685-92. doi: 10.12659/MSM.910955
- Huang V. Endogenous miRNAa: miRNA-mediated gene upregulation. Adv Exp Med Biol 2017; 983: 65-79. doi: 10.1007/978-981-10-4310-9_5
- Yamazaki K, Masugi Y, Effendi K, Tsujikawa H, Hiraoka N, Kitago M, et al. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Lab Invest 2014; 94: 683-91. doi: 10.1038/labinvest.2014.53
- Fan Q, Qiu M T, Zhu Z, Zhou J H, Chen L, Zhou Y, et al. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-beta/Smad3 signaling pathway. Oncol Rep 2015; 34: 1787-94. doi: 10.3892/or.2015.4143
- Chen X, Xiong D, Ye L, Wang K, Huang L, Mei S, et al. Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. Cancer Cell Int 2019; 19: 45. doi: 10.1186/s12935-019-0744-y
- Su Y, Xiong J, Hu J, Wei X, Zhang X, Rao L. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis. Oncotarget 2016; 7: 68397-411. doi: 10.18632/oncotarget.11722
- Yang J P, Yang X J, Xiao L, Wang Y. Long noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancer. Eur Rev Med Pharmacol Sci 2016; 20: 3980-6.